Robert Landewé
Impact in
- Rheumatology top 0.01%
- Spondyloarthritis Studies and Treatments
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Hematology top 0.1%
- Autoimmune and Inflammatory Disorders Research
Papers in
- Rheumatology 441
- Spondyloarthritis Studies and Treatments 288
- Rheumatoid Arthritis Research and Therapies 225
- Systemic Lupus Erythematosus Research 26
- Immunology 58
- Psoriasis: Treatment and Pathogenesis 46
- Co-authors
- Désirée van der Heijde (251 shared papers)Sofía Ramiro (105 shared papers)Maxime Dougados (76 shared papers)Astrid van Tubergen (54 shared papers)Jürgen Braun (34 shared papers)Maxime Dougados (12 shared papers)Josef S Smolen (15 shared papers)Tore K Kvien (17 shared papers)
- Journals
- Annals of the Rheumatic Diseases (184 papers)Lara D. Veeken (51 papers)RMD Open (45 papers)The Journal of Rheumatology (34 papers)Arthritis Research & Therapy (22 papers)
- Partner nations
- NetherlandsUnited StatesGermany
In The Last Decade
Robert Landewé
517 papers receiving 25.2k citations
Robert Landewé's Hit Papers
Peers
Comparison fields: 5 of 165
- Rheumatology 19.9k
- Hematology 3.5k
- Immunology 5.0k
- Orthopedics and Sports Medicine 1.5k
- Genetics 729
Countries citing papers authored by Robert Landewé
This map shows the geographic impact of Robert Landewé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Landewé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Landewé more than expected).
Fields of papers citing papers by Robert Landewé
This network shows the impact of papers produced by Robert Landewé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Landewé. The network helps show where Robert Landewé may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Landewé, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 538 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Dickkopf-1 is a master regulator of joint remodeling Hit paper breakdown → | 2007 | 1070 |
| 2 | Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis Hit paper breakdown → | 2008 | 744 |
| 3 | Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores Hit paper breakdown → | 2010 | 575 |
| 4 | Developing Core Outcome Measurement Sets for Clinical Trials: OMERACT Filter 2.0 Hit paper breakdown → | 2014 | 551 |
| 5 | Safety of synthetic and biological DMARDs: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis Hit paper breakdown → | 2014 | 546 |
| 6 | Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: A randomized clinical trial Hit paper breakdown → | 2005 | 545 |
| 7 | Certolizumab pegol plus methotrexate is significantly more effective than placebo plus methotrexate in active rheumatoid arthritis: Findings of a fifty‐two–week, phase III, multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group study Hit paper breakdown → | 2008 | 483 |
| 8 | EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis Hit paper breakdown → | 2013 | 477 |
| 9 | 2002 | 472 | |
| 10 | Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor α inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial Hit paper breakdown → | 2009 | 437 |
| 11 | Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept Hit paper breakdown → | 2008 | 427 |
| 12 | Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis Hit paper breakdown → | 2008 | 400 |
| 13 | Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study Hit paper breakdown → | 2013 | 362 |
| 14 | 2009 | 315 | |
| 15 | 2004 | 301 | |
| 16 | 2010 | 290 | |
| 17 | 2010 | 288 | |
| 18 | Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2013 update of the EULAR recommendations for the management of rheumatoid arthritis Hit paper breakdown → | 2014 | 275 |
| 19 | Safety of synthetic and biological DMARDs: a systematic literature review informing the 2016 update of the EULAR recommendations for management of rheumatoid arthritis Hit paper breakdown → | 2017 | 254 |
| 20 | 2014 | 249 |
About Robert Landewé
Robert Landewé is a scholar working on Rheumatology, Immunology, Hematology, Orthopedics and Sports Medicine and Pathology and Forensic Medicine, having authored 538 papers that have together received 26.2k indexed citations. Recurring topics across this work include Spondyloarthritis Studies and Treatments (288 papers), Rheumatoid Arthritis Research and Therapies (225 papers), Psoriasis: Treatment and Pathogenesis (46 papers), Autoimmune and Inflammatory Disorders Research (34 papers), Systemic Lupus Erythematosus Research (26 papers), Bone and Joint Diseases (25 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (16 papers) and Chronic Lymphocytic Leukemia Research (13 papers). The work is most often cited by research in Rheumatology (19.9k citations), Hematology (3.5k citations), Immunology (5.0k citations), Orthopedics and Sports Medicine (1.5k citations) and Genetics (729 citations). Robert Landewé has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Désirée van der Heijde, Sofía Ramiro, Maxime Dougados, Astrid van Tubergen, Jürgen Braun, Maxime Dougados, Josef S Smolen, Tore K Kvien, Xenofon Baraliakos and Joachim Sieper. Their work appears in journals such as Annals of the Rheumatic Diseases, Lara D. Veeken, RMD Open, The Journal of Rheumatology and Arthritis Research & Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.